Brown Advisory’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.77M Buy
+5,332
New +$1.85M ﹤0.01% 769

Other funds holding KRYS

Brown Advisory's KRYS Position: Q3 2026 in Review

Brown Advisory opened a new position in Krystal Biotech (KRYS) in Q3 2026: 5,332 shares worth $1.77M. The stake represents ﹤0.01% of the portfolio and ranks #769 among its holdings.

442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Brown Advisory held 5,332 shares of Krystal Biotech worth $1.77M as of Q3 2026.
  • Krystal Biotech was a new Brown Advisory position in Q3 2026.
  • Krystal Biotech made up ﹤0.01% of Brown Advisory's portfolio in Q3 2026, its #769 holding.
  • 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Brown Advisory's 13F filing for Q3 2026, filed 16 Nov 2026.